Purpose: to estimate the content of platelets and sP-selectin in patients with different severity of Hemorrhagic Feverwith Renal Syndrome. Materials and methods: we have conducted the clinical and laboratory examination of 220 patients with Hemorrhagic Fever with Renal Syndrome, including mild (52), moderate (112) and severe (56) forms. The quantitative content of sPselectin in blood serum was determined by enzyme immunoassay in 90 patients (30 people from each group). Results: during first days of admission to the hospital thrombocytopenia in patients with mild form of HFRS was moderate. For moderate and severe forms of HFRS during the initial period the average value of the platelet was less than 100u109/l; correlation analysis between platelet countand creatinine level revealed an inverse relationship between the platelet count during the initial period and the level of creatinine during the oliguric period (r=-0,526; p=0,029). The difference in the content of sP-selectin are statistically significant not only with the control group, but also between groups of patients depending on the severity of the disease, a correlation between the content of platelets and sP-selectin was revealed in all groups of patients. Conclusion: the activity of sP-selectin and the degree of thrombocytopenia are closely interrelated and characterize the severity of the disease.
Проведен анализ ассоциации полиморфных вариантов генов-мишеней, являющихся общими для микроРНК-146а, микроРНК-218, микроРНК-410, микроРНК-503, играющих роль в патогенезе геморрагической лихорадки, у пациентов с геморрагической лихорадкой с почечным синдромом (ГЛПС), инфицированных PUUV. Установлено, что генотип rs1127327*AA гена CCDC6 ассоциирован с понижением риска развития тяжелой формы заболевания. Необходимы дальнейшие исследования сети генов, являющихся мишенями различных микроРНК, для выяснения молекулярных механизмов, способных оказывать влияние на возникновение и развитие...
Objective. Evaluation of ischemic kidney damage in hemorrhagic fever with renal syndrome of severe severity using ultrasound techniques and urine gas analysis. Patients and methods. Fifty patients at the Republican Clinical Infectious Diseases Hospital, Izhevsk, aged 40.5[33.0;46.0] years in 2022–2023 with a diagnosis of HFRS and 42 patients with HFRS at the Republican Clinical Infectious Diseases Hospital, Ufa, aged 41.2[33.0;49.0] years in 2024 were examined. The diagnosis of hemorrhagic fever with renal syndrome, severity and complications were made in accordance with current clinical recommendations. Renal elastometry and renal artery Dopplerography were performed during the febrile period of the disease and during polyuria. The partial pressure of oxygen and carbon dioxide in urine was investigated at the time of transfer to the intensive care unit and transfer to the specialized department. Results. Disturbance of renal blood supply was manifested from the febrile period of the disease in the form of decrease of parenchyma stiffness parameters to 7.4 [5.5;8.1] kPa and vascularization to 2.0 [1.5;2.0] points, in oliguric period – decrease of oxygen partial pressure to 46.0 [45.0;47.0] mm Hg and increase of carbon dioxide to 65.0 [48.0;70.0] mm Hg in urine. The most pronounced impairment of renal blood supply was determined at stage 3 of acute kidney injury according to KDIGO classification, development of septic shock. Conclusion. Parameters characterizing the blood supply to the kidneys reflect the severity of the course of hemorrhagic fever with renal syndrome. Key words: blood supply to the kidney, hemorrhagic fever with renal syndrome
Aim. An analysis of coronavirus infection in Russia and evaluation of different AVT regimens effectiveness. Materials and methods. The study involved a retrospective analysis of 1082 patient records with laboratory-confirmed COVID-19 in 17 regions of Russia. The number of men and women was equal, mean age 48.718.1 (median 50). Patients with moderate COVID-19 (85%) versus mild COVID-19 (15%) were characterized by higher age (median 54 vs 21 years; p0.001), higher body mass index (27.8 vs 23.4; p0.001), prevalence of chronic diseases (75.3% vs 8.5%; p0.001), including circulatory system diseases (37.8%). Moderate COVID-19 characterized higher intoxication (10.86.1 vs 4.22.7 days; p0.001) and catarrhal symptoms duration (10.25.4 vs 6.14.1 days; p0.001). Results. During hospitalization 92% of the patients received AVT, 77% antibiotics, and 16% corticosteroids. Umifenovir therapy resulted in a significant reduction of intoxication (8.75.5 vs 11.75.5 days; p0.001) and catarrhal symptoms duration (8.85.1 vs 12.04.9 days; p0.001) compared to the group without AVT. The usage of INF reduced intoxication symptoms compared with the group without AVT (8.97.5 vs 11.75.5; p0.05). Therapy with hydroxychloroquine, imidazolylethanamide pentandioic acid, and lopinavir + ritonavir combination did not affect the course of COVID-19. Most of adverse reactions were related to antibiotics. Conclusion. Umifenovir therapy and inclusion of interferon in AVT regimens was associated improvement in the clinical manifestation of the disease among patients.